subject: Disappointing Earnings From Pfizer Pharmaceuticals For Coded Chinese Market - Pfizer - [print this page] Pfizer Pharmacy Emerging market company president for the biopharmaceutical industry works - Michelle? Halfon (Jean-MichelHalfon) at Thursday, said: "Pfizer's business in China increased by 25% to 28%, while its global overall growth in emerging markets 12% to 14%. "
He also said: "We will continue business in China rapid growth as China's middle class is increasing, more importantly, the Chinese government has begun to implement
Health Insurance Reform. We expect that this land will be a significant development. "
Pfizer to China, Brazil, India, Mexico, Russia and Turkey as an important emerging market, and to China as a top priority. Company said 2010 profit will be at least in China rose by 25%.
Pfizer in North Asia, Pakistan and India, emerging markets, regional president of the peninsula Allen? Gabriel (AllanGabor) said: "In fact, we do even better than expected."
According to prescription drugs Sell Data provider IMS Health Consulting in September 2003 forecast, to 2011, China may become the world's third largest
Drugs Market. Dispersed in the pattern of China's pharmaceutical market, the multinational pharmaceutical companies with up to 6,000 domestic pharmaceutical manufacturers to start a trial of strength, Pfizer holds a 2.2% market share.
"Our market share will increase, because we are committed to Pfizer's growth rate will be higher than the market average," Gable said, "It will share than it is now high, because we will continue to implement long-term strategy."
In January, Pfizer said it plans to increase the rapid growth in underdeveloped areas in the investment market and is expected to eventually generate stable profits.
Expanding sales team, establishing Cooperation Partnerships Pfizer said it planned to increase its sales representatives in China - many of them are trained doctor. 2011, 252 cities are expected to increase in 3200, an increase of 39%, while the number of the figure last year, 177 cities in 2300.
Pfizer said the medical representatives of many similar products in the promotion of Pfizer's vaccine
Anti-cancer drugs Material, cholesterol-lowering drug Lipitor (Lipitor), anti-hypertension drugs Norvasc (Norvasc) and
Antibiotic Drugs Zithromax (Zithromax). Gable said: "These people are medical information specialists. We will hire the person training in biological sciences. Many of whom have qualified doctors, their job is the most cutting-edge science into practical use of medical technology. "
Halfon (Halfon) said Pfizer adopted a different strategy with universities, medical associations, government agencies and other pharmaceutical companies forge partnerships to further expand the business scope of Pfizer Pharmaceuticals.
Pfizer and Japan's Takeda Pharmaceutical Co., Ltd. will cooperate to help the latter an important product in China
Diabetes Of drug pioglitazone (Actos) to enter the Chinese market.
Wednesday, Pfizer issued its disappointing earnings, next year's forecast earnings prospects are also bleak. The company expected 2010 earnings below the average analyst forecast, the company that the dollar will gain strength shrink. Pfizer is the pharmaceutical industry in the performance of sluggish earnings quarter, a representative of failure due to patent protection, those who bring the drugs can not be profitable to continue to make original contributions to the industry.
Analysts said, the pharmaceutical industry giant swine flu incident in 2009, received additional profits, but the lethality of the virus than people originally expected to be low. For large pharmaceutical companies, 2010 is a more difficult period.
